硫酸長春堿作用機(jī)制 - Medchemexpress - MCE中國

1、Product Data SheetVinblastine sulfateCat. No.: HY-13780CAS No.: 143-67-9分式: CHNOS分量: 909.05作靶點(diǎn): Microtubule/Tubulin; Autophagy作通路: Cell Cycle/DNA Damage; Cytoskeleton; Autophagy儲存式: 4C, protect from light* In solvent : -80C, 6 months; -20C, 1 month (protect from light)溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 44 mg/mL (48.4

2、0 mM)* means soluble, but saturation unknown.SolventMass1 mg 5 mg 10 mgConcentration制備儲備液1 mM 1.1000 mL 5.5002 mL 11.0005 mL5 mM 0.2200 mL 1.1000 mL 2.2001 mL10 mM 0.1100 mL 0.5500 mL 1.1000 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液；旦配成溶液，請分裝保存，避免反復(fù)凍融造成的產(chǎn)品失效。儲備液的保存式和期限：-80C, 6 months; -20C, 1 month (protect fro

3、m light)。-80C 儲存時(shí)，請?jiān)?6 個(gè)內(nèi)使，-20C 儲存時(shí)，請?jiān)?1 個(gè)內(nèi)使。體內(nèi)實(shí)驗(yàn)請根據(jù)您的實(shí)驗(yàn)動物和給藥式選擇適當(dāng)?shù)娜芙獍浮Ｒ韵氯芙獍付颊埾劝凑?In Vitro 式配制澄清的儲備液，再依次添加助溶劑：為保證實(shí)驗(yàn)結(jié)果的可靠性，澄 的儲備液可以根據(jù)儲存條件，適當(dāng)保存；體內(nèi)實(shí)驗(yàn)的作液，建議您現(xiàn)現(xiàn)配，當(dāng)天使； 以下溶劑前顯的百分 指該溶劑在您配制終溶液中的體積占；如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象，可以通過加熱和/或超聲的式助溶1. 請依序添加每種溶劑： 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (

4、2.75 mM); Clear solution此案可獲得 2.5 mg/mL (2.75 mM，飽和度未知) 的澄清溶液。以 1 mL 作液為例，取 100 L 25.0 mg/mL 的澄 DMSO 儲備液加到 400 L PEG300 中，混合均勻；向上述體系中加50 L Tween-80，混合均勻；然后繼續(xù)加 450 L 理鹽定容 1 mL。2. 請依序添加每種溶劑： 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (2.75 mM); Clear solution此案可獲得 2.5 mg/mL (2.75 mM，飽和度未

5、知) 的澄清溶液。以 1 mL 作液為例，取 100 L 25.0 mg/mL 的澄 DMSO 儲備液加到 900 L 20% 的 SBE-CD 理鹽溶液中，混合Page 1 of 2 www.MedChemE均勻。3. 請依序添加每種溶劑： 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (2.75 mM); Clear solution此案可獲得 2.5 mg/mL (2.75 mM，飽和度未知) 的澄 溶液，此案不適于實(shí)驗(yàn)周 期在半個(gè)以上的實(shí)驗(yàn)。以 1 mL 作液為例，取 100 L 25.0 mg/mL 的澄 DMSO 儲備液加到 900 L 油中

6、，混合均勻。BIOLOGICAL ACTIVITY物活性 Vinblastine sulfate 值為8.9 M。種針對各種癌癥類型的有細(xì)胞毒性的物堿。 長春花堿可抑制微管的形成，抑制nAChR的IC50IC & Target IC50: 8.9 M(nAChR)1體外研究 Vinblastine does not depolymerize spindle microtubules, yet it powerfully blocks mitosis (for example, IC50 0.8 nM inHeLa cells) and cells die by apoptosis2. In N

7、B4 cells, vinblastine produces alteration of p53 and DNA fragmentation.Vinblastine treatment has an antiproliferative effect via the induction of apoptosis producing Bax/Bcl-2 imbalance.Vinblastine treatment suppresses NFB expression and depresses NFB-DNA binding activity while maintaining JNKactiva

8、tion that subsequently results in apoptotic response through caspase-dependent pathway3. Vinblastine isfound to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential, the release of bothcytochrome c and apoptosis inducing factor, activation of caspase-9 and 3, and cleavage o

9、f Poly (ADP-ribose)-Polymerase4.體內(nèi)研究 Vinblastine is a widely used anticancer drug with undesired side effects. Its conjugation with carrier molecules couldbe an efficient strategy to reduce these side effects5.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Biochem Pharmacol. 2020 Mar 3:113865. Mutat Res Genet Toxicol Environ Mutagen.

10、 2016 Sep 15;808:27-37. Int J Clin Exp Pathol. 2017;10(3):3033-3042.See more customer validations on HYPERLINK www.MedChemE www.MedChemEREFERENCES1. McKay DB, et al. Nicotinic and nonnicotinic receptor-mediated actions of vinblastine. Proc Soc Exp Biol Med. 1993 Jul;203(3):372-6.2. Pandya P, et al.

11、Molecular recognition pattern of cytotoxic alkaloid vinblastine with multiple targets. J Mol Graph Model. 2014 Nov;54:1-9.3. Calvi?o E, et al. JNK and NFB dependence of apoptosis induced by vinblastine in human acute promyelocytic leukaemia cells. Cell Biochem Funct. 2015Jun;33(4):211-9.4. Selimovic

12、 D, et al. Vinblastine-induced apoptosis of melanoma cells is mediated by Ras homologous A protein (Rho A) via mitochondrial and non-mitochondrial-dependent mechanisms. Apoptosis. 2013 Aug;18(8):980-97.5. Bnczi Z, et al. Synthesis and in vitro antitumor effect of vinblastine derivative-oligoarginine conjugates. Bioconjug Chem. 2010 Nov 17;21(11):1948-55.Page 2 of 3 www.MedChemEMcePdfHeightCaution: Product has not b